Premium
Adjunctive raloxifene improves cognition in schizophrenia
Publication year - 2015
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30092
Subject(s) - raloxifene , selective estrogen receptor modulator , placebo , schizophrenia (object oriented programming) , medicine , crossover study , cognition , pharmacology , estrogen receptor , psychiatry , cancer , breast cancer , alternative medicine , pathology
The selective estrogen receptor modulator raloxifene significantly improved memory and attention/processing speed relative to placebo in a 13‐week crossover trial that included both men and women with schizophrenia. Raloxifene did not result in a reduction in symptom severity, however.